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Highlights
Advanced tools and resources are available to silence or overexpress Anopheles genes
Precise genome editing is broadly applicable to multiple Anopheles species
Proof of principle for Anopheles population suppression and modification are successful in 
laboratory settings 
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Abstract
Anopheles is the only genus of mosquitoes that transmit human malaria and consequently the focus of 
large scale genome and transcriptome-wide association studies. Genetic tools to define the function of 
the candidate genes arising from these analyses are vital. Moreover, genome editing offers the potential 
to modify Anopheles population structure at local and global scale to provide complementary tools 
towards the ultimate goal of malaria elimination. Major breakthroughs in Anopheles genetic analysis 
came with the development of germline transformation and RNA interference technology. Yet, the field 
has been revolutionized again by precise genome editing now possible through site-specific nucleases. 
Here we review the components of the current genetic toolkit available to study Anopheles, focusing 
particularly on how these technical advances are used to gain insight into malaria transmission and the 
design of genetic methods to control Anopheles vectors. 
Introduction
Malaria, transmitted solely by Anopheles spp. mosquitoes, remains the most important global vector 
borne disease and a priority target for control, local eradication and global elimination. Despite the 
halving of global malaria deaths between 2000-2015, mainly due to enormous programs that 
successfully targeted Anopheles vectors with insecticide treated nets, 445,000 people still die annually 
from the disease and some indicators point to a stalling of progress [1]. There is therefore an urgent 
need to tackle malaria transmission using all the methods available, including improved insecticide, 
vaccine and drug development. To complement these public health approaches to disease control, 
advances in genetic methods have promised ‘realizable’ tools that will bolster the fight against 
Anopheles mosquitoes. 
Large scale comparative sequencing projects are currently used to identify genes that potentially impact 
malaria transmission [2]. Understanding the physiological function of these candidate genes requires 
techniques that silence, mutate or overexpress them in vivo to characterize the resultant alteration in 
phenotype. Here we will review these genetic tools (summarised in Table1), illustrated with recent 
insights into how they may be used to study the mosquito biology influencing vectorial capacity, 
including the latest advances that are directed towards Anopheles population control.
2Functional genetic analysis
RNA interference (RNAi)
Main current use: rapid validation of the effects of gene knockdown on vector phenotype
Perhaps the most widely used method for genetic analysis in Anopheles mosquitoes has been RNAi. The 
technique can be highly gene specific, since it relies on near complete homology to target specific 
mRNAs for degradation (reviewed in [3]). The technique is based on the natural cellular response to the 
detection of double stranded (ds) RNA. After introducing synthetic dsRNA homologous to a target gene, 
the cellular machinery processes this template to direct cleavage of complementary mRNA, thereby 
reducing the encoded protein level over time (Fig 1A).
A recent extensive example of this approach involved silencing Anopheles innate immunity genes using a 
phenotype readout of prevalence and intensity of Plasmodium infection [4]. These experiments 
demonstrated that the antagonistic and agonistic effectors [5,6] of Plasmodium development are 
differentially expressed in alternative Anopheles species in response to the intensity of parasite burden. 
This robust technique has also been applied to many other diverse aspects of Anopheles biology ranging 
from insecticide resistance [7] to heart rate [8]. Although most commonly used in adults, the technique 
can also be successfully applied to embryos [9] to study developmental gene function and, with some 
difficulty, to pupae [10]. Larvae do not survive the injection process well, and techniques have been 
recently modified to silence larval genes by feeding chitosan/dsRNA nanoparticles or bacteria/yeast 
expressing dsRNAs [11].
Overall, the technique provides rapid assessment of loss of gene function phenotypes, however in 
anophelines not all genes and/or tissues are targeted efficiently [12] and so care is needed to monitor 
protein (or mRNA) turnover. In addition, off-target silencing has the potential to complicate analysis, but 
has not been extensively studied in anophelines [3]. Nevertheless, the major advantage of this approach 
is that the effect of gene silencing can be monitored stage-specifically, which can often be more difficult 
to achieve with other methods.
By targeting vital genes, RNAi may play a role in anopheline and malaria control. Perhaps the closest to 
translation are RNAi-based larvicides delivered as dried pellets to defined larval breeding sources to 
provide Anopheles specific killing with limited toxicity to other organisms [11].
Transposable elements
Main current use: assaying phenotypes produced by tissue specific and ectopic expression of 
transgenes, promoter trapping, creating docking lines for comparative analysis
The RNAi methodology offers a one stage or one generation approach to loss of function analysis, and so 
needs to be continuously repeated to provide experimental material. By modification of germline 
chromosomes, stable mosquito lines are generated that inherit loss or gain of gene function 
phenotypes. Such transgenic anopheline lines were firstly created using processes adopted from 
Drosophila methodologies. These included embryo microinjection targeted to developing germline cells, 
permissive transposable element transformation vectors (Minos and PiggyBac) (Fig 1B) that catalyse 
integration of themselves (and linked DNA cargoes) into germline chromosomes, and promoter 
sequences to drive expression of selectable marker genes to visually detect the rare transgenic progeny 
[13,14]. Using these transposon-based methods and a range of cloned tissue-specific promoters [15] to 
regulate transgene expression, stable Anopheles mosquito lines can be generated that ectopically 
express endogenous/foreign genes or dsRNAs to examine phenotypic consequences of increased or 
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refractory strains of Anopheles have been developed through midgut expression of a number of 
different gene families [16].  
The integration sites of transposons are nearly-random in the genome, often leading to variability in 
expression between lines carrying the same transgene in different genomic locations (position effect), 
and to insertional mutagenesis if transposon integration disrupts a coding sequence. The end result is 
that multiple lines need to be generated to draw reliable conclusions on the phenotype.
Although their use is likely to be superseded by the flexibility of site-specific approaches, the random 
nature of transposon insertion makes them particularly useful for unbiased screening techniques such as 
promoter trapping, whereby DNA regulatory regions can be identified following the insertion of a 
promoter-less fluorescent reporter gene in their vicinity [17]. Transposon integration can also be used to 
screen for genomic sites that produce limited fitness cost and consistent transgene expression [18], 
suitable for docking lines described in the following section.
Site directed integration
Main current use: comparative functional analysis 
To normalise position effect variation of expression, docking lines have been created that direct the 
insertion of genes into ‘tagged’ genomic sites through the site-directed recombinase phiC31 [19]. This is 
achieved by including a recombinase docking (attP) site in the integrated transgene to create a stable 
line tagged at a defined locus. Alternative transgenes can then be inserted into this locus by including a 
donor (attB) site in the new transformation vectors and a source of PhiC31 enzyme to catalyse the 
recombination reaction (Fig 1Ci). Each line should express the alternative transgenes at similar temporal 
and spatial patterns and levels allowing robust comparison of relative gene function. 
The phiC31 recombinase can also be used to precisely exchange transgenes into defined genomic sites 
(Fig 1Cii) by placing an attP site on either side of the docking transgene [18]. New DNA constructs 
carrying flanking attB sequences will then swop into these sites by recombination to seamlessly replace 
the original transgene [20].
A number of docking anopheline lines are now available and further refinements are discussed in [21]. 
This review also introduces a flow cytometry method (COPASTM) which allows rapid fluorescence 
screening of live mosquito larvae that speeds the process of generating and characterising transgenic 
lines.
Bipartite expression systems
Main current use: to study toxic genes, comparative functional analysis
The scope of Drosophila genetic analysis has been based largely on the use of bipartite expression 
systems. By separating the transgene under analysis (responder) from the regulatory regions controlling 
its expression (driver) in distinct transgenic lines, genes causing extreme fitness or developmental 
phenotypes can be examined in the progeny of driver and responder line crosses (Fig 1D). As well as 
examining toxic genes, bipartite systems also provide a flexible platform for comparative tissue specific 
expression analysis whereby different effector genes can be assayed in multiple expression patterns 
simply by crossing appropriate responder and driver lines. 
Different bipartite systems have been utilized in Anopheles. The tTA/tetO system has been developed 
for gut [22] and flight muscle [23] specific expression in An. stephensi. Similarly, the GAL4/UAS has been 
used for enhancer trapping in An. stephensi [17], and ubiquitous [18] and gut specific expression [24] in 
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neurons [25]. 
In the latter case, piggyBac insertions created driver lines carrying the An. gambiae odorant receptor co-
receptor (orco) promoter controlling QF2 transcription activator expression and responder lines carrying 
QF2 binding sites (QUAS) upstream of a membrane-localised green fluorescent protein (mGFP) gene. In 
the progeny of driver and responder crosses, the mGFP localisation recapitulated the endogenous orco 
expression pattern, and hence fluorescently tagged all neurons bearing olfactory receptors. In this way 
olfactory innervations that may be involved in host recognition were exquisitely mapped. The bipartite 
system generated opens one way to express reporter genes that can monitor real time activity in 
discreet neuronal families to define the olfactory ‘code’ of odour recognition during host seeking. 
Moreover, by adoption of the many other reporter based approaches used in Drosophila, it may be 
possible to modulate and disrupt host-seeking behaviour [25].
Site specific nucleases
Main current uses: site specific genome editing, gene knockout and knockin
The advent of relatively flexible and powerful genome editing tools based on a range of site-specific 
nucleases offers the potential for a vast array of precise genome modifications which is revolutionizing 
genetic analysis in Anopheles, as in other model and non-model organisms [26]. They all rely on site 
specific endonuclease cleavage of germline DNA that is repaired in the cell by either i) ‘imperfect’ non 
homologous end joining (NHEJ) that most often creates frameshift mutations, or ii) homology directed 
repair (HDR) whereby homologous sequences are used as a recombination template to repair the 
damage. HDR can be exploited by providing transgenes flanked by homologous sections around the 
known cut site, so that during repair the transgene cargo is copied into a precisely defined location.
Although not published extensively yet in Anopheles, it is relatively straightforward to mutate or insert a 
DNA cargo into virtually any genomic location desired, particularly in the case of Cas9 modifications as 
described and illustrated in Fig 1E. 
Such site specific genome editing has been performed in anophelines using homing nucleases [27], 
transcription activator-like effector nucleases (TALENs)[28-30], and Cas9 nucleases [20,31-33]. With 
homing endonucleases and TALENs, specific genomic sequences targeted for cleavage are recognized 
directly by the nuclease, and so altering the target site can be a fairly intensive protein/DNA engineering 
process. Nevertheless, a homing endonuclease was the first used in Anopheles for site specific 
modification [27] (see below), and more recently TALENs were created for both gain and loss of function 
analysis of the TEP1 complement-like protein in An. gambiae to examine its role in Plasmodium killing 
[29,30]. A TALEN kynurenine 3-monooxygenase gene knockout in An. stephensi [28] also answered a 
long-standing question on the role of mosquito-derived xanthurenic acid in stimulating Plasmodium 
development in the mosquito midgut. 
The CRISPR/Cas9 methods are generally much simpler to perform, since the Cas9 endonuclease is 
directed to a specific DNA locus site by a unique, complementary short guide RNA which can be rapidly 
designed and synthesised. Highly efficient CRISPR/Cas9-mediated NHEJ mutagenesis of visible 
phenotypic markers [31] has been demonstrated in multiple Anopheles species, as well as efficient HDR 
in An. stephensi [32] and An. gambiae [20], supporting the broad potential applications across the 
genus. With continual refinements in targeting efficiency, CRISPR/Cas9-based analysis thus seems likely 
to dominate genome modification approaches for the foreseeable future.
Most of the recent applications of CRISPR/Cas9 in anophelines have been in the field of gene drives and 
will be discussed in more detail below. However, the potential applications of CRISPR/Cas9 in functional 
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into coding regions to create gene knockouts, substitution of genes or fluorescent protein tagging, 
chromosome rearrangement, regulation of gene expression, and chromatin modification. The above list 
of potential applications is far from exhaustive and further developments will undoubtedly broaden this 
portfolio as technological improvements increase control, efficiency and specificity. 
As neurobiological examples, it would be relatively straightforward to target different classes of sensory 
neurons (e.g. Fig 2 – Anopheles chordotonal organs) to co-express bipartite drivers with specific 
neuronal genes by Cas9-mediated HDR.  By appropriate design and fusion with a 2A self-cleaving 
peptide [34], the driver coding sequence could be inserted into a known neuronal specific gene to 
achieve bicistronic expression regulated by the native promoter. Co-translational cleavage would be 
expected to produce equimolar amounts of the two proteins in active forms that would create a 
neuronal driver suitable to express a variety of reporters. These may include fluorescent tags for 
anatomical mapping [25], genetically encoded ion sensors to follow real time activation [35], and 
knockout constructs to examine loss of function phenotypes. More simply, gene knockout and 
mutagenesis could be used to validate neurological target sites of novel insecticidal compounds.
Applications for malaria control
Two general strategies are being pursued for control of malaria through the release of genetically 
modified (GM) mosquitoes. One involves reducing the effective population size of Anopheles 
mosquitoes (suppression), while the other aims at reducing the number of infectious bites people 
receive without affecting population size (modification).
Population suppression strategies 
Generally, suppression strategies aim at reducing the vector population size by impairing their ability to 
successfully reproduce (reviewed in [36-38]). A combination of transposon and site directed genetic 
approaches contributed to create anopheline lines displaying population suppressive traits. 
PiggyBac transformed lines were used to express homing nucleases that cleaved zygotic X chromosomes 
resulting in male sterility [39], which was further refined to bias production of male-only progeny [40]. 
Sex distortion was demonstrated again using transposon-mediated insertion of CRISPR/Cas9 
components resulting in selective destruction of X chromosome-bearing sperms [41]. Flight, and thus 
mating capability, has also been targeted through tTA regulated expression of apoptotic effectors in 
female flight muscles [23]. More recently, female-targeted suppression was reported in phiC31 cassette 
exchange-derived lines carrying CRISPR/Cas9 alleles that knocked out three ovarian genes in An. 
gambiae [20] rendering females essentially sterile. In the near future, the increasing knowledge of 
Anopheles sex determination [9,42] and the improved capability of modifying the Y chromosome [43] 
will greatly contribute to genetic sex distorting technologies. 
Population modification strategies 
While suppression strategies are based on introducing a significant fitness load into the population, 
modification (or replacement) approaches rely on the introgression of traits that impair parasite 
development in the vector to limit malaria transmission. 
Various strategies for the creation of GM anophelines that are refractory to infection have been 
exploited and are reviewed in [44]. Successful parasite blocking relies on tightly regulated promoters 
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midgut, haemolymph, and salivary glands) to coincide with parasite development following ingestion. 
To date, most strategies to modify transmission have relied on the use of transposon or integrase-
mediated strategies to express different effector genes including: endogenous or exogenous 
antimicrobial molecules; interaction inhibitor molecules; or the sustained activation of antiparasitic 
signalling pathways [16,44]. RNAi and then later CRISPR/Cas9-based NHEJ approaches have also been 
exploited to silence the parasite agonist fibrinogen-related protein-1 in An. gambiae [33,45]. While 
these strategies result in a significant decrease of Plasmodium prevalence and/or intensity of infection, 
they most often impose fitness costs that may also be indirectly responsible for parasite load reductions.
A more specific anti-Plasmodium approach involves supplementing mosquito innate immunity by 
expressing single chain antibodies (scFvs) that target antigens expressed on the parasite surface during 
development within the mosquito [46]. In view of their specific blocking capacity and the fact that these 
mosquitoes appear as fit as wild type under the conditions tested [47], expression of multiplexed scFvs 
is perhaps the most promising current approach for population modification.   
Gene drives 
While proof-of-principle experiments for population suppression and modification have been successful, 
strategies that would rely on reiterative mass release of mosquitoes to spread a trait are very costly, and 
a drive system for the rapid introgression of favourable traits into a wild population from relatively low 
threshold numbers is likely to be more readily achieved and sustained.
Gene drives are based on genetic elements that are inherited with a frequency greater than Mendelian 
segregation rates, which allows them to spread in a population in relatively few generations, 
theoretically even against a degree of fitness cost [37] (Fig 3). While gene drives are not a new concept 
[48], the advent of programmable site-specific nucleases made their application more tractable [37,49] 
The first proof of principle for a gene drive in anophelines was based on the expression of the homing 
nuclease I-SceI [27] targeting a modified transgenic GFP. Cage trials indicated high drive efficiency and 
opened the potential for similar systems to force desirable traits into populations. More recently, 
CRISPR/Cas9 was used to generate two further gene drives  [50]. A population modification system was 
successfully developed in An. stephensi to drive scFvs directed against Plasmodium proteins into a caged 
population with >99% efficiency [32]. Shortly after, a population suppression gene drive was described 
in An. gambiae that targeted one of the aforementioned candidate ovary specific genes for knockout 
and showed around 75% drive efficiency in caged populations [20].
These initial studies showcase the immense potential for transforming populations, but a number of 
significant hurdles need to be overcome before they can be used in real world scenarios for disease 
control. These issues and potential proposed solutions are extensively discussed in the indicated articles 
and include: technical obstacles, such as the generation of resistance to the drive [51,52]; concerns 
about standards for laboratory confinement [53,54]; the feasibility of conducting safe and ethical field 
trials [55] and options for recalling, limiting spread or stopping the drive once released [56]. In this 
context, modelling of long term population dynamics will be critical to predict potential epidemiological 
outcomes, as well as longer term effects on biodiversity and ecosystems [57-59]. 
While still in their infancy, CRISPR/Cas9-based gene drives hold out a promise of very powerful, cost-
effective and self-sustainable tools to be added to the malaria control toolbox. Moreover, the ongoing 
advances in genetic technologies enable the discovery of gene functions that will inform and direct 
improvements in current intervention strategies through greater knowledge of vector biology.
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8Table 1. Comparison of genetic manipulation techniques in Anopheles
Basis of 
modification
RNA Interference
         Transient                          Stable
Transposon Integrase/recombinase Bipartite expression 
systems
Site specific nucleases
 System used Synthetic dsRNA 
injection/feeding
Transgenic 
expression of 
hairpin RNA
Minos
PiggyBac
phiC31 tTA
Gal4/UAS
Q
HEGS
TALENS
CRISPR
Anopheles
Species 
modified
An. gambiae/coluzzii 
[3]
An. stephensi [60]
An. arabiensis [9]
An. dirus [61]
An. sinensis [10]
An. aquasalis [62]
An. stephensi [63] An. gambiae/coluzzii [13]
An. stephensi [14]
An. albimanus [64]
An. gambiae/coluzzii [19]
An. stephensi [47]
An. gambiae/coluzzii 
[24,25]
An. stephensi [22]
An. 
gambiae/coluzzi[20,27,29,31]
An. stephensi [32]
An. funestus [31,32]
An. albimanus [31,32]
Site of 
integration
N/A Dependant on 
integration system 
used.
Essentially random 
(TTAA for piggyBac, TA 
for Minos)
Site directed into pre-
existing attP tagged sites 
in the genome.
Dependant on 
integration system 
used.
Predetermined, targeted 
genomic sites.
Advantages Rapid;
Relatively high 
throughput;
Can be targeted to 
adult stages.
Tissue and temporal 
specific knockdown;
Heritable 
knockdown.
Unbiased integration; 
Suitable for locus, fitness, 
and enhancer/exon 
screening;
Can be remobilised for 
mutation screens.
Comparative analysis of 
genes expressed at same 
genomic locus.
Greater cargo size than 
TEs.
Suitable for toxic and 
developmental genes; 
Flexible analysis of 
tissue specific 
phenotypes.
Vast array of mutations and 
expression regulated lines 
can be created. Can utilise 
endogenously located 
promoters and genes for 
mutagenesis.
Potential drives are easily 
designed (CRISPR/Cas9).
Drawbacks Transient; 
One generation only; 
Does not target all 
genes/tissues equally.
Longer time to 
generate through 
transgenesis;
May be selected 
against during 
maintenance.
Positional variegation of 
expression;
Limited number of 
promoters available;
Limited cargo size 10-12 
Kb.
Need to create docking 
lines initially;
Limited number of 
promoters available.
Multiple lines need to 
be maintained.
Limited number of 
promoters available.
Except CRISPR/Cas9, quite 
extensive engineering 
required.
Normally creates null 
mutations, potentially 
inviable if dominant.
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Figure 1. 
A) RNA interference (RNAi)
Synthetic double stranded RNA (dsRNA) homologous to the target gene transcript are typically injected into the 
mosquito haemocoel, where they are taken up by some tissue types (including fat body, oenocytes, haemocytes and 
midgut) and cleaved by the Dicer ribonuclease into small (~20 nt) interfering dsRNAs (siRNAs). These are 
incorporated into the RNA-induced silencing complex (RISC) which degrades one strand, while the other strand 
directs the silencing complex to the target mRNA. After strict complementarity-based binding, the RISC nuclease 
Argonaute (Argo) catalyzes the cleavage and thus inactivation of the mRNA. Several days are left to allow for protein 
turnover, after which phenotypic assays are performed versus control mosquitoes. 
B) The PiggyBac Transposon 
Embryos are injected at the posterior pole (germline localization) with a donor plasmid carrying the transgene flanked 
by piggyBac inverted terminal repeats (ITR) and a transient source of transposase (TR), either plasmid encoded, 
mRNA or purified protein. The TR recognizes the ITRs and catalyzes the “cut and paste” of the cassette into a 
“random” TTAA sequence in the germline chromosome. Insertion preserves the ITRs and if transposase is supplied 
in later generations, remobilization of the cassette can occur. Modification of the germline is passed onto the next 
generation and can be followed by monitoring expression of a fluorescent marker gene (such as dsRed) linked to the 
transgene. Transgenes will normally consist of a promoter to drive tissue specific expression of a downstream 
effector gene followed by a signal sequence to terminate transcription.
C) The PhiC31/att system. 
Embryos of phiC31 docking lines carrying (i) one or (ii) two attP sites in a defined chromosomal locus are injected 
with a donor plasmid carrying a transgene and fluorescent protein gene flanked by one (i) or two (ii) attB sites and a 
transient source of integrase (INT). i) Integration. The integrase catalyzes the recombination at the att sites resulting 
in the integration of the entire donor plasmid DNA into the genomic docking site. ii) Cassette exchange. The 
integrase catalyzes double crossover recombination the att sites resulting in the swap of the originally integrated 
cassette and removal of the plasmid backbone. The alternative transgenes are generally marked with distinct 
fluorescent proteins to facilitate inheritance screening. Recombination results in the formation of hybrid sites attR and 
attL that are resistant to remobilization. 
D) Binary expression systems. 
In anophelines, three types of bipartite expression systems have been developed: the tTA/tetO, GAL4/UAS, and Q 
systems. All comprise of separate driver lines that express a transcriptional activator factor under regulation of a 
desired promoter, and responder lines carrying the gene of interest downstream of corresponding activation factor 
binding sites. When the two components are brought together in the progeny of driver and responder crosses the 
transgene will be expressed and potential phenotype observed. The driver construct dictates the temporal and spatial 
pattern of expression; the responder construct determines which protein is expressed. The lines are usually marked 
with different fluorophores to facilitate screening for co-inheritance. GAL4, QF and tTA are transcriptional activators 
from yeast, Neurospora crassa, and E. coli respectively. UAS, QUAS and tetO are their corresponding binding sites. 
The tTA systems are responsive to tetracycline, and so gene expression can be switched on/off by supplying 
mosquitoes with tetracycline analogues. The GAL4 and QF system can be switched off by co-expressing either Gal80 
or Q-S suppressors respectively in the same tissues (although this has not yet been performed in anophelines).
E) CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas9 site-specific mutagenesis. 
During embryo injection, a transient source of site-specific endonuclease Cas9 is provided alongside a short (-20 nt) 
guide RNA (gRNA), either in vitro transcribed, plasmid encoded or synthesised, which has perfect complementarity to 
the sequence targeted for modification. The target site is defined by and lies immediately adjacent to a protospacer 
adjacent motif (PAM) with sequence NGG. The Cas9 is directed to a desired genomic target by the gRNA and 
creates a double stranded DNA break that is precisely located 3 bp upstream of the PAM site. Chromosome integrity 
is restored by the cell DNA repairing machinery using either of two different mechanisms: Non-Homologous End 
Joining (NHEJ) or Homology Directed Repair (HDR). NHEJ results from the imprecise ligation of the broken DNA 
extremities which in most cases causes frameshift indel mutations and thus gene knockout when occurring in coding 
regions. HDR occurs when donor DNA having significant homology surrounding the breakpoint is used by the cell as 
a template to repair the break. By including a desired cargo (e.g. promoters, markers, mutagenised genes, tags) 
flanked by sequences homologous to the surrounding breakpoint locus into the co-injected donor DNA template, 
these are precisely incorporated into the genomic site via homologous recombination.  
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Figure 2. Anopheles chordotonal organs
A, B, C: Piggybac transformed An. gambiae carrying an alpha-tubulin promoter fusion with eGFP and dsRed 
fluorescent marker driven by the synthetic neuronal promoter Pax3. Fluorescently tagged chordotonal 
(mechanosensory) organs (yellow arrows) are visible through the cuticle and hence readily available for real time vital 
imaging in A) larval abdomen and thorax, B) dorsal side of the adult thorax and C) the junction of thorax and femur 
[65].  D) Immuno-stained section of Johnston’s organ (JO) or the male mosquito antennal ‘ear’; phalloidin (actin - 
blue) and anti-HRP (neuronal membrane marker - red), courtesy of Marta Andres Miguel [66]. The JO is a complex 
chordotonal organ located at the base of the flagellum (distal part of antennae) and contains over 15,000 auditory 
neurons that transduce sound-induced mechanical vibrations from the flagellum into electrical signals. 
The auditory neurons are bipolar and monodendritic, with ciliated dendritic outer segments pointing towards and 
indirectly coupled to the base of the flagellum. The auditory neurons are arranged in groups of 2-3 and form together 
with two accessory cell functional units called scolopidia. Mosquitoes mate in swarms, and males detect potential 
mates by tuning into the wing-beat frequency of conspecific females. Analysis of mosquito hearing has many 
avenues for mosquito control, including insecticides that target signal transduction, genetic control targeting mating 
success and acoustic traps.
Figure 3. CRISPR/Cas9-based gene drives.  
To create a gene drive, the germline transformation is designed so that the gRNA and Cas9 are included in the 
knockin construct and so are incorporated into the cleaved target site on the chromosome or so called ‘drive’ allele by 
HDR. The chromosomally encoded Cas9 will then cut the wild type allele on the homologous chromosome, which by 
HDR is converted into another drive allele. By using promoter sequences to drive nuclease expression in early 
germline tissues, most or all of the gametes will thus contain a drive allele which will be inherited by up to 100% of the 
subsequent progeny. Other genes (cargo) can be included along with the nuclease to encode desired traits that will 
be also inherited at the same frequency as the drive, and/or if the target sequence is within a coding region then this 
gene will be knocked out simultaneously during HDR. 
In the suppression drives designed to date, the inheritance of the drive allele disrupts the coding region of genes that 
regulate reproductive capacity. If Cas9 activity is restricted to the germline, then fertile somatic heterozygotes, will 
carry homozygous gene drives in the germline and pass on the drive at super-Mendelian rates. In time, the increase 
of drive allele frequency will produce a predominance of somatic infertile homozygotes that results in a crash of 
population size. 
In modification drives, genes conferring refractoriness to malaria are inherited at super-Mendelian rates along with 
the drive. Depending on the degree of fitness costs due to modification, the antimalarial trait will introgress into the 
population while the overall size will not be affected. 
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